CAS RN: 1416713-53-5
6-bromo-1-cyclopropyl-1H-benzo[d]imidazole
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250210
100mg / 250mg / 1g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1416713-53-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Shanghai
Inquiry
1416713-53-5 / 6-bromo-1-cyclopropylbenzimidazole
Standard CAS: 1416713-53-5
Multi CAS: No
Basic Information
copy
CAS
1416713-53-5 copy
Multi CAS
No copy
Molecular Formula
C10H9BrN2 copy
Molecular Weight
237.100000 copy
Exact Mass
235.994910 copy
SMILES
C1CC1N2C=NC3=C2C=C(C=C3)Br copy
InChI
InChI=1S/C10H9BrN2/c11-7-1-4-9-10(5-7)13(6-12-9)8-2-3-8/h1,4-6,8H,2-3H2 copy
InChIKey
YVEVNYLEDGYGDK-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.3 copy
Rotatable bonds
1 copy
H-bond acceptors
2 copy
Molar refractivity
55.7 copy
TPSA
17.82 copy
LogP / Solubility
WLOGP
3.13 copy
MLOGP
2.76 copy
XLogP3
2.6 copy
Consensus LogP
2.83 copy
Log S (ESOL)
-3.73 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.77 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.92 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.94 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy